According to the scoring criteria as described in the Materials and Methods, 35% (39 out of 111 case), 19% (21 out of 111 cases), 65% (72 out of 111 cases) and 41% (45 out of 111 cases) were considered positive for CCL5 in stromal cells and CCR1, 3 and 5 in carcinoma cells, respectively. This evidence concerns the gene CCR1 and carcinoma.